408 related articles for article (PubMed ID: 34167552)
1. Chitosan nanoparticles as a promising tool in nanomedicine with particular emphasis on oncological treatment.
Sharifi-Rad J; Quispe C; Butnariu M; Rotariu LS; Sytar O; Sestito S; Rapposelli S; Akram M; Iqbal M; Krishna A; Kumar NVA; Braga SS; Cardoso SM; Jafernik K; Ekiert H; Cruz-Martins N; Szopa A; Villagran M; Mardones L; Martorell M; Docea AO; Calina D
Cancer Cell Int; 2021 Jun; 21(1):318. PubMed ID: 34167552
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and optimization of chitosan nanoparticles: Potential applications in nanomedicine and biomedical engineering.
Ghadi A; Mahjoub S; Tabandeh F; Talebnia F
Caspian J Intern Med; 2014; 5(3):156-61. PubMed ID: 25202443
[TBL] [Abstract][Full Text] [Related]
3. Recent advances of chitosan-based nanoparticles for biomedical and biotechnological applications.
Gao Y; Wu Y
Int J Biol Macromol; 2022 Apr; 203():379-388. PubMed ID: 35104473
[TBL] [Abstract][Full Text] [Related]
4. Understanding the mechanisms of silica nanoparticles for nanomedicine.
Li Z; Mu Y; Peng C; Lavin MF; Shao H; Du Z
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1658. PubMed ID: 32602269
[TBL] [Abstract][Full Text] [Related]
5. Recent Progress in Chitosan-Based Nanomedicine for Its Ocular Application in Glaucoma.
Albarqi HA; Garg A; Ahmad MZ; Alqahtani AA; Walbi IA; Ahmad J
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36840002
[TBL] [Abstract][Full Text] [Related]
6. The Potential of Chitosan in Nanomedicine: An Overview of the Cytotoxicity of Chitosan Based Nanoparticles.
Frigaard J; Jensen JL; Galtung HK; Hiorth M
Front Pharmacol; 2022; 13():880377. PubMed ID: 35600854
[TBL] [Abstract][Full Text] [Related]
7. Application of Chitosan and its Derivatives in Nanocarrier Based Pulmonary Drug Delivery Systems.
Dua K; Bebawy M; Awasthi R; Tekade RK; Tekade M; Gupta G; De Jesus Andreoli Pinto T; Hansbro PM
Pharm Nanotechnol; 2017; 5(4):243-249. PubMed ID: 28786352
[TBL] [Abstract][Full Text] [Related]
8. Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment.
Choukaife H; Seyam S; Alallam B; Doolaanea AA; Alfatama M
Int J Nanomedicine; 2022; 17():3933-3966. PubMed ID: 36105620
[TBL] [Abstract][Full Text] [Related]
9. Multi-functional chitosan-based nanoparticles for drug delivery: Recent advanced insight into cancer therapy.
Tian B; Hua S; Liu J
Carbohydr Polym; 2023 Sep; 315():120972. PubMed ID: 37230614
[TBL] [Abstract][Full Text] [Related]
10. Formulation and
Viswanadh MK; Vikas ; Jha A; Reddy Adena SK; Mehata AK; Priya V; Neogi K; Poddar S; Mahto SK; Muthu MS
Nanomedicine (Lond); 2020 Oct; 15(24):2345-2367. PubMed ID: 32945225
[No Abstract] [Full Text] [Related]
11. Chitosan nanoparticles: a promising system in novel drug delivery.
Nagpal K; Singh SK; Mishra DN
Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1423-30. PubMed ID: 21048331
[TBL] [Abstract][Full Text] [Related]
12. Tumor-Targeting Glycol Chitosan Nanoparticles for Cancer Heterogeneity.
Ryu JH; Yoon HY; Sun IC; Kwon IC; Kim K
Adv Mater; 2020 Dec; 32(51):e2002197. PubMed ID: 33051905
[TBL] [Abstract][Full Text] [Related]
13. Gold nanoparticles: emerging paradigm for targeted drug delivery system.
Kumar A; Zhang X; Liang XJ
Biotechnol Adv; 2013; 31(5):593-606. PubMed ID: 23111203
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and Therapeutic Nanomedicine.
Joo J
Adv Exp Med Biol; 2021; 1310():401-447. PubMed ID: 33834444
[TBL] [Abstract][Full Text] [Related]
15. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, Bioapplications, and Toxicity Evaluation of Chitosan-Based Nanoparticles.
Rizeq BR; Younes NN; Rasool K; Nasrallah GK
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31744157
[TBL] [Abstract][Full Text] [Related]
17. Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine.
Jang SF; Liu WH; Song WS; Chiang KL; Ma HI; Kao CL; Chen MT
Int J Mol Sci; 2014 Mar; 15(3):3904-25. PubMed ID: 24599081
[TBL] [Abstract][Full Text] [Related]
18. Advances in self-assembled chitosan nanomaterials for drug delivery.
Yang Y; Wang S; Wang Y; Wang X; Wang Q; Chen M
Biotechnol Adv; 2014 Nov; 32(7):1301-1316. PubMed ID: 25109677
[TBL] [Abstract][Full Text] [Related]
19. Multicomponent, Tumor-Homing Chitosan Nanoparticles for Cancer Imaging and Therapy.
Key J; Park K
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28282891
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticles in nanomedicine: a comprehensive updated review on current status, challenges and emerging opportunities.
Abdel-Mageed HM; AbuelEzz NZ; Radwan RA; Mohamed SA
J Microencapsul; 2021 Sep; 38(6):414-436. PubMed ID: 34157915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
